Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/AZ_5M9rqfNM/238054.php
Thursday, 24 November 2011
Tumor-Homing Peptide Delivers Treatment That Shrinks Tumors And Minimizes Side Effects
The trouble with most anti-cancer therapies is that they are lethal to most cells in the body, not just cancer cells. As a result, patients experience side effects like nausea, increased susceptibility to infection, and increased risk of developing secondary cancers later in life. Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) are developing techniques to deliver cancer drugs directly to tumors, increasing their effectiveness and decreasing collateral damage...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment